Last deal

$1.33M
Local Amount - GBP 972K

Amount

Convertible Note

Stage

02.02.2021

Date

3

all rounds

$4.81M

Total amount

date founded

Financing round

General

About Company
Quin provides digital therapeutics for personalized independent self-management of diabetes.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Ayuda Heuristics, Quin Tech

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Convertible Note

IPO status

Private

Description

Quin is a provider of digital therapeutic services that empowers individuals to manage their diabetes on their own through a groundbreaking personalization model. Unlike other diabetes platforms, Quin focuses on the 24x7 needs of the individual living with the condition, improving their health outcomes and wellbeing. The first Quin app is a novel digital therapeutic for personalized independent self-management of type 1 diabetes, which has been highly successful, ranking in the top #1-3 most-downloaded diabetes apps in the App Store in the UK and Ireland. Early data shows that Quin has the potential to improve time-in-range by 10-20% for those starting at less than 70%. Quin's personalization model will also benefit people with type 2 diabetes and other chronic conditions.
Contacts

location

Contact Email

Social url

Legal Names

Legal name

Quin Technology LTD.
Similar Companies
454
mySugr

mySugr

mySugr is a digital health company that simplifies life with diabetes.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Apps

Location

Vienna, Austria

total rounds

3

total raised

$5.98M
Gendius

Gendius

Gendius is a diabetes management platform that helps people manage their diabetes effectively.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Chester, UK

total rounds

5

total raised

$995.75K

DiabeticU, Inc.

DiabeticU is a technology company revolutionizing diabetes management.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology
DiabetesLab

DiabetesLab

DiabetesLab offers a mobile health application that uses AI algorithms to help diabetic patients manage their health.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Mobile Apps, Artificial Intelligence
M&A Details
1

Transaction name

Acquired by

Infohealth

announced date

05.08.2022

Financials

Funding Rounds
7
3

Number of Funding Rounds

$4.81M

Money Raised

Their latest funding was raised on 02.02.2021. Their latest round Convertible Note

Date 
Funding Round 
Investors 
Money Raised 
Lead 
02.02.2021
$1.33M
Local Amount - GBP 972K
01.07.2020
$121.12K
Local Amount - GBP 97.16K
04.05.2020
$802.68K
Local Amount - GBP 645K
Co-Investors

People

Founders
1
Isabella Degen
Isabella Degen

Isabella Degen

organization founded

1

Isabella Degen

Employee Profiles
5
Barry Rogers

Barry Rogers

VP of Prroduct

Vyvyan Codd

Code magician

Cyndi Mitchell

Cyndi Mitchell

Founder

Vanessa Bolosier

Vanessa Bolosier

Head of Marketing

Activity

Recent News
0